Back
G1 Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
GTHX
Sponsored
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Sell
46
GTHX
G1 Therapeutics
Last Price:
7.16
Seasonality Move:
-14.81%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.G1 Therapeutics Price Quote
$7.16
+0.01 (+0.14%)
(Updated: September 19, 2024 at 6:24 AM ET)
G1 Therapeutics Key Stats
Sell
46
G1 Therapeutics (GTHX)
is a Sell
Day range:
$7.15 - $7.15
52-week range:
$1.08 - $7.19
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.40
P/B ratio:
15.34%
Volume:
0
Avg. volume:
3.1M
1-year change:
379.87%
Market cap:
$377.2M
Revenue:
$82.5M
EPS:
$-0.86
How Much Does G1 Therapeutics Make?
-
How Much Are G1 Therapeutics's Sales Annually?
GTHX Revenues are $82.5M -
How Much Profit Does G1 Therapeutics's Make A Year?
GTHX net income is -$48M
Is G1 Therapeutics Growing As A Company?
-
What Is G1 Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.61% -
What Is G1 Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
G1 Therapeutics Stock Price Performance
-
Did G1 Therapeutics Stock Go Up Last Month?
G1 Therapeutics share price went up by 0.56% last month -
Did GTHX's Share Price Rise Over The Last Year?
GTHX share price rose by 379.87% over the past 1 year
What Is G1 Therapeutics 52-Week High & Low?
-
What Is G1 Therapeutics’s 52-Week High Share Price?
G1 Therapeutics has traded as high as $7.19 over the past 52 weeks -
What Is G1 Therapeutics’s 52-Week Low Share Price?
G1 Therapeutics has traded as low as $1.08 over the past 52 weeks
G1 Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy G1 Therapeutics?
-
How Much Debt Does G1 Therapeutics Have?
Total long term debt quarterly is $44.3M -
How Much Cash Does G1 Therapeutics Have?
Cash and short term investments quarterly total is $60.7M -
What Is G1 Therapeutics’s Book Value Per Share?
Book value per share is 0.47
Is G1 Therapeutics Cash Flow Positive?
-
What Is GTHX Cash Flow From Operations?
Cash flow from operations (TTM) is -$37.5M -
What Is G1 Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$8.4M -
What Is G1 Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $5.1M
G1 Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
GTHX return on invested capital is -52.13% -
What Is G1 Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -37.11% -
What Is GTHX Return On Equity?
ROE is a measure of profitability and is -118.89%
G1 Therapeutics Earnings Date & Stock Price
-
What Is G1 Therapeutics's Stock Price Today?
A single share of GTHX can be purchased today for 7.15 -
What Is G1 Therapeutics’s Stock Symbol?
G1 Therapeutics trades on the nasdaq under the ticker symbol: GTHX -
When Is G1 Therapeutics’s Next Earnings Date?
The next quarterly earnings date for G1 Therapeutics is scheduled on November 1, 2024 -
When Is GTHX's next ex-dividend date?
G1 Therapeutics's next ex-dividend date is May 20, 2020 -
How To Buy G1 Therapeutics Stock?
You can buy G1 Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
G1 Therapeutics Competitors
-
Who Are G1 Therapeutics's Competitors?
Below is a list of companies who compete with G1 Therapeutics or are related in some way:
G1 Therapeutics Dividend Yield
-
What Is GTHX Dividend Yield?
G1 Therapeutics’s dividend yield currently is 0% -
What Is G1 Therapeutics’s Payout Ratio?
G1 Therapeutics’s payout ratio is 0% -
When Did G1 Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is G1 Therapeutics’s Dividend Per Share?
G1 Therapeutics pays a dividend of $0.00 per share
G1 Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 38.05% |
Revenue: | -60.97% | 3.24% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 7.15 |
Upside from Last Price: | 0% |